CVE-2024-27086 Details
UNDERGOING ENRICHMENT
The CVE is currently being enriched by the Volerion team. The enrichment process results in the association of reference link tags, CVSS, and CPE applicability statement data.
Description
The MSAL library enabled acquisition of security tokens to call protected APIs. MSAL.NET applications targeting Xamarin Android and .NET Android (e.g., MAUI) using the library from versions 4.48.0 to 4.60.0 are impacted by a low severity vulnerability. A malicious application running on a customer Android device can cause local denial of service against applications that were built using MSAL.NET for authentication on the same device (i.e., prevent the user of the legitimate application from logging in) due to incorrect activity export configuration. MSAL.NET version 4.60.1 includes the fix. As a workaround, a developer may explicitly mark the MSAL.NET activity non-exported.
Metrics
CVSS 4.0 Severity and Vector Strings:
VolerionCVSS-B:…Vector:This vulnerability is currently being analyzed.No CVSS 4.0 data is available for this CVE.
CVSS 3.x Severity and Vector Strings:
VolerionCVSS-B:…Vector:This vulnerability is currently being analyzed.No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Jul 26, 2024References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-863 | Incorrect Authorization | [email protected] |
| CWE-926 | Improper Export of Android Application Components | [email protected] |
Affected Products
This vulnerability is currently being analyzed
Change History
5 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Nov 21, 2024 | CVE Modified | CVE |
| May 14, 2024 | CVE Modified | [email protected] |
| Apr 16, 2024 | New CVE Received | [email protected] |